Most articles about low testosterone jump straight to treatment. This one does not. Before asking whether testosterone replacement is safe, or who should be managing it, it is worth understanding what is actually happening inside the body as testosterone falls with age. This is the "why", the honest biology behind the decline, grounded in the evidence, not alarmist about aging itself. If you are further along and weighing treatment, our companion articles on whether testosterone therapy is safe and on why the specialist managing your care matters cover that ground in detail.
How testosterone normally works
Testosterone production is governed by a feedback loop called the hypothalamic-pituitary-gonadal (HPG) axis. The brain releases signals that prompt the pituitary gland to secrete two hormones, LH and FSH, which in turn instruct the Leydig cells in the testes to produce testosterone. It is a tightly regulated system that continuously adjusts output based on circulating hormone levels. Our other articles go into more depth on what happens when this system is supported with treatment; here, the focus is on what happens to it, on its own, as men age.
Why it declines with age: the actual mechanisms
According to a 2024 review in Reproductive Biology and Endocrinology, total serum testosterone declines at roughly 0.4% per year in men aged 40 to 70, with the decline beginning gradually from around age 35. Free testosterone, the biologically active portion not bound to carrier proteins, falls faster still, at roughly 1.3% per year. This is not a minor academic detail: low testosterone in aging men has been associated with increased risk of diabetes, dementia, cardiovascular disease, and mortality, and it can adversely affect fertility.
The decline traces back to aging's effect on the HPG axis and, more directly, on the Leydig cells themselves, the specialized testosterone-producing cells in the testes. A few specific mechanisms are worth understanding.
The cholesterol-transport machinery slows down. Making testosterone starts with cholesterol, which has to be transported into the Leydig cell's mitochondria before it can be converted into hormone. That transport is carried out by a protein complex, sometimes called the "transduceosome," built around proteins including StAR, TSPO, and VDAC1. Aging appears to impair this cholesterol-transport machinery, which means less raw material reaches the site where testosterone is actually manufactured, independent of whether the brain's signaling to the testes is intact.
Cellular stress responses play a role. Endoplasmic reticulum (ER) stress, and the cell's "unfolded protein response" to it, has been implicated in Leydig cell aging and dysfunction. It is worth being precise about the evidence here: in mouse models specifically, heat-induced ER stress suppressed a key enzyme in the testosterone-production pathway (3-beta-HSD) and reduced testosterone output, and this effect was reversible with ER stress inhibitors in aged mouse Leydig cells. This is animal-model evidence. It has not yet been shown to translate directly into a human treatment, but it does point to a plausible cellular mechanism behind the decline.
Autophagy, the cell's cleanup process, also declines. Autophagy is the process by which cells clear out damaged components and recycle them. Dysfunction in this process has also been implicated in aging Leydig cell decline, though this is a newer, less fully characterized part of the picture, worth mentioning briefly rather than overstating.
Taken together, these mechanisms describe a testis that, with age, becomes less efficient at the basic cellular job of turning cholesterol into testosterone, layered on top of any changes higher up in the HPG axis.
What actually helps, honestly
Given that mechanism, what does the evidence say can meaningfully support testosterone levels, short of treatment?
Exercise, with an honest caveat. One small study of 7 elderly men (mean age 70) found that short-term moderate exercise transiently raised total testosterone by 39% and the free testosterone index by 23%, but levels returned to baseline within 4 hours. That is a real but temporary spike, not a lasting fix, and it should not be oversold as one. A separate, larger study of 202 patients (mean age 51.8, mean BMI 28.5) followed for around 15 weeks found a more sustained increase in total testosterone with regular exercise. Taken together with general evidence that 150 minutes per week of moderate aerobic activity carries substantial health benefits in large cohort studies, regular exercise, particularly resistance and strength training, appears to support healthier testosterone levels in older individuals over time, though higher-quality clinical trials are still needed to define exactly how much and what type.
Weight management is the primary lever. Excess body fat lowers testosterone partly through increased conversion of testosterone into estrogen (aromatization) in fat tissue. This makes diet and activity, the tools that reduce excess adiposity, the primary, evidence-based approach for men whose testosterone decline is compounded by weight. In a randomized controlled trial, an estrogen-modulating medication used off-label for this purpose raised serum testosterone after 12 weeks in men with obesity-related testosterone decline. This is not a first-line recommendation. It is based on limited studies, with unclear long-term risk-benefit, and it is the kind of decision that belongs to individualized specialist judgment on a case-by-case basis, not a general suggestion for every man carrying extra weight.
Neither of these replaces a proper evaluation. If you are noticing symptoms of low testosterone and are wondering whether the underlying decline warrants treatment, that is a different, related question, one our articles on testosterone therapy safety and choosing the right specialist for TRT are built to answer.
- Total testosterone declines roughly 0.4% per year from around age 35 to 70; free testosterone declines faster, roughly 1.3% per year.
- The decline traces to aging's effects on the HPG axis and, more directly, on the testosterone-producing Leydig cells in the testes.
- At a cellular level, aging impairs the cholesterol-transport machinery (StAR, TSPO, VDAC1) that Leydig cells need to manufacture testosterone.
- Endoplasmic reticulum stress and reduced autophagy are also implicated in Leydig cell aging, though much of this comes from animal-model research so far.
- Exercise and weight management are the two evidence-based levers, exercise's effect can be partly transient, and weight management works largely through reducing testosterone-to-estrogen conversion; medication is a specialist-guided, case-by-case option, not a first-line fix.